Figure 4

Kaplan-Meier curve between a more sensitive group and a more resistant group as defined as above or below the median value. Patients receiving IPC with at least one sensitive drug were included in the sensitive group (n = 15) and those receiving only resistant drugs were included in the resistant group (n = 8). Only CC 0 patients from the colorectal cancer group were included in the analysis. p = 0.4.